Investor Relations


Precigen Event and Presentation
Monday, January 7, 2019
3:00pm PST

Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, held an event on Monday, January 7, 2019 during the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. Helen Sabzevari, PhD, President, Precigen, presented at the event. The presentation provided an overview of the company, the long-term vision for the company, and an introduction and overview of current preclinical and clinical programs in immuno-oncology, autoimmune disorders and infectious diseases. The replay can be accessed through Intrexon’s website in the Investors section under ‘Events’ at